Schroder UK Public Private Trust (SUPP)

Sector:

Investment Firms

Index:

FTSE Small Cap

33.05p
   
  • Change Today:
    -0.050p
  • 52 Week High: 90.00
  • 52 Week Low: 28.60
  • Currency: UK Pounds
  • Shares Issued: 908.64m
  • Volume: 728,002
  • Market Cap: £300.31m
  • RiskGrade: 284

Woodford Patient Capital Trust scores 6.9% NAV increase

By Duncan Ferris

Date: Friday 05 Apr 2019

LONDON (ShareCast) - (Sharecast News) - Woodford Patient Capital Trust climbed on Friday as it reported an increase in net asset value after a number of companies in its portfolio entered the commercialisation phase.
The FTSE 250 listed trust, which is run by fund manager Neil Woodford, reported a 6.9% increase in net assets to £0.81m for 2018, up from £0.76m the year before, while net asset value per share rose to 97.61p from 91.33p.

Susan Searle, chair of Woodford Patient Capital, said: "Last year, I commented on tangible signs that many of the companies in the Woodford Patient Capital Trust (WPCT) portfolio were making good progress and that we hoped to see this reflected in financial performance in the forthcoming year. The progress made by some of WPCT's larger unquoted holdings has resulted, in part, in the increase in net asset value during the period of 6.9%."

Among the biggest success stories was Autolus, which completed its initial public offering and saw its shares were 90% higher than the initial $17 per share price.

Woodford holds a 10.2% stake in the business T-cell therapy developer.

"The portfolio's success stories are gradually beginning to account for a larger proportion of assets, so this has meant that the contribution from the positive uplifts was significantly greater than the contribution from the negatives," said Woodford. manager.

Others that contributed to the uplift in NAV included artificial intelligence firm Beneveolent AI, British gene analysis Oxford Nanopore and Welsh proton therapy facilities developer Proton Partners International, which entered the commercialisation phase in 2018.

"The objective of WPCT remains the same. The portfolio is well established with strength and depth, while there have been solid signs of progress this year. The Portfolio Manager has previously stated that performance should be judged on a three-to-five-year view," said Searle.

Woodford Patient Capital Trust's shares were up 2.96% at 83.40p at 1549 BST.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

SUPP Market Data

Currency UK Pounds
Share Price 33.05p
Change Today -0.050p
% Change -0.15 %
52 Week High 90.00
52 Week Low 28.60
Volume 728,002
Shares Issued 908.64m
Market Cap £300.31m
RiskGrade 284

SUPP Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
87.45% below the market average87.45% below the market average87.45% below the market average87.45% below the market average87.45% below the market average
97.82% below the sector average97.82% below the sector average97.82% below the sector average97.82% below the sector average97.82% below the sector average
Income Not Available
Growth
63.32% below the market average63.32% below the market average63.32% below the market average63.32% below the market average63.32% below the market average
52.1% below the sector average52.1% below the sector average52.1% below the sector average52.1% below the sector average52.1% below the sector average

SUPP Dividends

  Latest Previous
  Final Final
Ex-Div n/a 19-May-16
Paid n/a 10-Jun-16
Amount 0.000p 0.16p

Trades for 21-Jan-2020

Time Volume / Share Price
16:35 161,055 @ 33.05p
16:26 12,032 @ 33.24p
16:21 928 @ 33.10p
16:00 6,000 @ 33.32p
15:29 2,445 @ 33.11p

SUPP Key Personnel

Chair Susan Searle

Top of Page